logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12576212 B1

PDFFull Text
Date of Patent:
Mar. 17, 2026

Filed:

Jul. 11, 2022

Medicine injection and disease management systems, devices, and methods

Applicant:

Bigfoot Biomedical, Inc., Milpitas, CA (US);

Inventors:

John Sjolund, Los Altos, CA (US);

Ambika Srinath, San Francisco, CA (US);

Andrew Bochenko, Redwood City, CA (US);

George Crothall, Oceanside, CA (US);

Bryan Mazlish, Palo Alto, CA (US);

Lane Desborough, Thousand Oaks, CA (US);

Jennifer Martin Block, Menlo Park, CA (US);

Sarah Matarese, San Jose, CA (US);

Linda Mackowiak, Cazenovia, NY (US);

Assignee:

Bigfoot Biomedical, Inc., Milpitas, CA (US);

Attorney:

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Primary Examiner:

Eric J Messersmith

Int. Cl.
CPC ...
A61M 5/315 (2006.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61K 38/28 (2006.01); A61M 5/00 (2006.01); A61M 5/168 (2006.01); A61M 5/20 (2006.01); A61M 5/32 (2006.01); G16H 20/13 (2018.01); G16H 20/17 (2018.01); G16H 20/60 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); A61M 5/142 (2006.01); A61M 5/24 (2006.01); A61M 5/31 (2006.01);
U.S. Cl.
CPC ...
A61M 5/31546 (2013.01); A61B 5/0004 (2013.01); A61B 5/14532 (2013.01); A61B 5/4836 (2013.01); A61B 5/4839 (2013.01); A61B 5/7405 (2013.01); A61B 5/7435 (2013.01); A61B 5/7455 (2013.01); A61B 5/746 (2013.01); A61K 38/28 (2013.01); A61M 5/003 (2013.01); A61M 5/168 (2013.01); A61M 5/20 (2013.01); A61M 5/31525 (2013.01); A61M 5/3202 (2013.01); G16H 20/13 (2018.01); G16H 20/17 (2018.01); G16H 20/60 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); A61B 5/14546 (2013.01); A61B 5/681 (2013.01); A61M 2005/14208 (2013.01); A61M 2005/2006 (2013.01); A61M 5/24 (2013.01); A61M 2005/3125 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3306 (2013.01); A61M 2205/3561 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/502 (2013.01); A61M 2205/505 (2013.01); A61M 2205/581 (2013.01); A61M 2205/582 (2013.01); A61M 2205/583 (2013.01); A61M 2209/06 (2013.01); A61M 2230/201 (2013.01);
Abstract

Diabetes management systems may include a glucose monitoring device adapted to transmit glucose data and at least one accessory in communication with the glucose monitoring device and adapted to provide at least one alarm or alert based on the glucose data.

Find Patent Forward Citations

Sjolund, John. (2026). Medicine injection and disease management systems, devices, and methods (U.S. Patent No. 12576212). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12576212

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…